IGF studies have indicated oncogene transformation, tumor proliferation, and tumor growth regulation by type 1 IGF receptor (IGF-1R), IGF-1, and insulin [7], identifying IGF signaling a viable therapeutic target. This evidence concerns the gene INS and neoplasm.